3.0
20120717
NRB-13738
Tislelizumab-FOLFOX
1
3
COMPLETED
NONE
0.00
42
NO
Emetogenicitet:Medel.\n\nKurintervall: 42 dagar.\n\n
https://kunskapsbanken.cancercentrum.se/redirect/regim/13738
https://kunskapsbanken.cancercentrum.se/redirect/regim/13738
Regimbiblioteket
20260327
NO
FLUID
IVINF
0
0
WARD
NONE
250
0
ML
ANTIDOTE
PO
0
0
WARD
NONE
0
MG
STANDARD
SUBSTANCE
IVINF
0
30
PHARMACY
NONE
400
0
MG
STANDARD
100
0
ML
SUBSTANCE
IVINF
0
60
PHARMACY
NONE
85
0
MG
SURFACE
250
0
ML
ANTIDOTE
IVINF
0
60
WARD
NONE
400
0
MG
SURFACE
250
0
ML
SUBSTANCE
IVINJ
0
3
PHARMACY
NONE
400
0
MG
SURFACE
SUBSTANCE
IVINF
46
0
PHARMACY
NONE
2400
0
MG
SURFACE
NO
FLUID
IVINF
0
0
WARD
NONE
250
0
ML
ANTIDOTE
PO
0
0
WARD
NONE
0
MG
STANDARD
SUBSTANCE
IVINF
0
60
PHARMACY
NONE
85
0
MG
SURFACE
250
0
ML
ANTIDOTE
IVINF
0
60
WARD
NONE
400
0
MG
SURFACE
250
0
ML
SUBSTANCE
IVINJ
0
3
PHARMACY
NONE
400
0
MG
SURFACE
SUBSTANCE
IVINF
46
0
PHARMACY
NONE
2400
0
MG
SURFACE
NO
FLUID
IVINF
0
0
WARD
NONE
250
0
ML
ANTIDOTE
PO
0
0
WARD
NONE
0
MG
STANDARD
SUBSTANCE
IVINF
0
60
PHARMACY
NONE
85
0
MG
SURFACE
250
0
ML
ANTIDOTE
IVINF
0
60
WARD
NONE
400
0
MG
SURFACE
250
0
ML
SUBSTANCE
IVINJ
0
3
PHARMACY
NONE
400
0
MG
SURFACE
SUBSTANCE
IVINF
46
0
PHARMACY
NONE
2400
0
MG
SURFACE